_PRIVATE_LIMITED_435502.webp)
Amjay Medimax (India) Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 17-07-2024
- Paid Up Capital ₹ 3.10 M
as on 17-07-2024
- Company Age 26 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1,159.97 Cr
as on 17-07-2024
- Satisfied Charges ₹ 329.04 Cr
as on 17-07-2024
- Revenue -74.15%
(FY 2023)
- Profit -2513.02%
(FY 2023)
- Ebitda -1809.15%
(FY 2023)
- Net Worth -136.36%
(FY 2023)
- Total Assets -62.85%
(FY 2023)
About Amjay Medimax (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.10 M.
The company currently has active open charges totaling ₹1,159.97 Cr. The company has closed loans amounting to ₹329.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Amit Jain and Asit Jain serve as directors at the Company.
- CIN/LLPIN
U33112GJ1998PTC034598
- Company No.
034598
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Amjay Medimax (India) Private Limited offer?
Amjay Medimax (India) Private Limited offers a wide range of products and services, including Face Mask & Medical PPE Kits, Personal Protective Equipment, Face Mask, Bakery & Dairy Machinery, Bread Making Machine.
Who are the key members and board of directors at Amjay Medimax (India)?
Financial Performance of Amjay Medimax (India).
Amjay Medimax (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.15% decrease. The company also saw a substantial fall in profitability, with a 2513.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 136.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amjay Medimax (India)?
In 2023, Amjay Medimax (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sbicap Trustee Company Limited Creation Date: 23 Mar 2015 | ₹1,159.97 Cr | Open |
India Infoline Finance Limited Creation Date: 28 Feb 2014 | ₹1.88 Cr | Satisfied |
India Infoline Finance Limited Creation Date: 28 Feb 2014 | ₹8.50 M | Satisfied |
How Many Employees Work at Amjay Medimax (India)?
Amjay Medimax (India) has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amjay Medimax (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amjay Medimax (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
